Page last updated: 2024-08-17

aniline and Granulocytic Leukemia, Chronic

aniline has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Broudy, MI; Cai, L; Chen, I; Clackson, T; Commodore, L; Dalgarno, DC; Huang, WS; Iuliucci, J; Keats, J; Li, F; Liu, S; Metcalf, CA; Ning, Y; Qi, J; Rivera, VM; Romero, J; Russian, K; Sawyer, TK; Shakespeare, WC; Snodgrass, JT; Sundaramoorthi, R; Thomas, M; Wang, F; Wang, Y; Wardwell, S; Wen, D; Xu, Q; Zhou, T; Zhu, X; Zou, D	1

Other Studies

1 other study(ies) available for aniline and Granulocytic Leukemia, Chronic

Article	Year
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant. Bioorganic & medicinal chemistry letters, 2011, Jun-15, Volume: 21, Issue:12 Topics: Administration, Oral; Alkynes; Aniline Compounds; Animals; Cyclization; Disease Models, Animal; Fusion Proteins, bcr-abl; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Models, Molecular; Molecular Structure; Mutation; Rats; Structure-Activity Relationship; Toluene	2011

Article

Year

Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant.

Bioorganic & medicinal chemistry letters, 2011, Jun-15, Volume: 21, Issue:12

Topics: Administration, Oral; Alkynes; Aniline Compounds; Animals; Cyclization; Disease Models, Animal; Fusion Proteins, bcr-abl; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Models, Molecular; Molecular Structure; Mutation; Rats; Structure-Activity Relationship; Toluene

2011